×

Levothyroxine compositions having unique triiodothyronine Tmax properties

  • US 20030195254A1
  • Filed: 08/14/2002
  • Published: 10/16/2003
  • Est. Priority Date: 08/14/2001
  • Status: Abandoned Application
First Claim
Patent Images

1. An immediate release pharmaceutical composition comprising a levothyroxine salt, wherein the composition exhibits a triiodothyronine (T3) plasma Tmax of between from about 10 hours to about 20 hours as determined by the standard Tmax test.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×